Virginia BioTechnology Center
Virginia BioTechnology Center
Virginia BioTechnology Center
800 East Leigh Street
Richmond, VA 23219
Size: 27,000 square feet
Cost: $5,000,000
Year Opened: 1995
Features: Administrative offices for the Virginia BioTechnology Research Park; wet laboratory and office suites for start-up and early-stage life science companies; common equipment and shared facilities including cold rooms, autoclaves, dishwashers, DI water, icemakers, freezers; auditorium, conference and meeting rooms; kitchen and catering facilities; mail, receiving, copying reception and other office support functions.
Tenant Listing
- AmpliPhi
- Bill Police, LLC
Assists businesses in managing their cell phone bills more cost effectively by simplifying the bill into one easy-to-read format, identifying and correcting billing errors with the carrier, suggesting more cost-effective alternatives and providing historical trend analysis. Its proprietary software application is web-enabled and will serve not only cell phone users but also future applications involving wireless data and wireless applications. Possible examples include wireless timecards or global positioning. Bill Police's target market is businesses with 10 or more mobile phones. Typical monthly cost savings average 25 percent. Additional cost savings of time and manpower also are significant. The price is $5 or $7 per subscriber per month.
Kae K. Zulager, CEO
Phone: (804) 640-3334
Email: kae@billpolice.comRonald V. Carpenter, Senior VP
Phone: (804) 640-3332
Email: ron@billpolice.comClifton L. Rogers, branch operations manager
Phone: (804) 422-1560
Email: cliff@billpolice.comDaren Carpenter, Director of IT
Email: daren@billpolice.com - Bio Cancell Therapeutics, Inc.
BioCancell Therapeutics, Inc., a biopharmaceuticals corporation, has developed patient-oriented, and therefore patient-specific, targeted therapy for the treatment of numerous types of cancer. The treatment is based on utilizing the H-19 gene — an important oncofetal gene — expressed at high levels in more than 30 types of human cancer tissues, while existing at a nearly undetectable level in the surrounding normal tissues. BioCancell Therapeutics was founded in 2004 by Professor Abraham Hochberg, professor of molecular biology at the Hebrew University of Jerusalem. BioCancell's R&D activities are conducted through its wholly owned Israel-based subsidiary,
BioCancell Therapeutics, Ltd.
Donna Edmonds
Phone: (804) 212-2975
Fax: (804) 828-8566
Email: dedmonds@vbcc-inc.com - BioProtect
BioProtect has developed an innovative medical device platform consisting of a biodegradable, inflatable balloon that can be implanted into the body with a quick, minimally invasive process. The device can be used to enhance prostate cancer treatment by moving healthy tissue from the radiation pathway. This technology leads to decreased side effects and allows for increased radiation intensity and fewer overall treatment sessions. The device can also be used in the orthopedic market to assist with successful repair of rotator cuff tears.
Kate Webster
Phone: (804) 212-2299
Fax: (804) 828-8566
Email: kwebster@vbcc-inc.com - BluePrint Genomics, Inc.
BPG focuses on development and application of high-throughput genomic technologies in the area of personalized medicine.
Gregory A. Buck, Ph.D.
Phone: (804) 852-4137
Email: blueprintgenomicsinc@gmail.com - Castle Technologies
Develops and implements enterprise-wide health informatics applications, with proven expertise in areas such as case management, disease management and utilization management. Founded in 1994 in Richmond, Va., Castle is an 8(a)- and MBE/DBE-certified company that has provided I.T. solutions for managed care, state Medicaid/Medicare, for-profit and nonprofit organizations.
http://www.castletechnologies.com
Justin Samson, president
Phone: (804) 747-3761
Fax: (804) 747-3636
Email: info@castletechnologies.com - Cupron, Inc.
Cupron has developed a unique and efficient platform technology that promises to dramatically improve public health and prevent the spread of disease. Utilizing the unique qualities of copper, Cupron's patented technology adds a broad-spectrum antimicrobial (antibacterial, antiviral, antifungal and anti-mite) compound to a wide range of products through use of nontoxic chemical processes. Emerging data is very compelling in embedded products and in wound care.
John D. Cudzik
Phone: (804) 780-0069
Fax: (804) 828-8566
Email: jdcudzik@cupronmedical.com - eHealthObjects
- EnzySurge Ltd.
EnzySurge Ltd. is a developer and provider of innovative solutions for the treatment and management of chronic wounds. EnzySurge's patented and FDA-cleared DermaStream™ - an innovative wound care platform, which together with a set of advanced bio-active solutions, forms the basis for the new and unique wound treatment modality - Continuous Streaming Therapy™. CST enables a new, controlled chronic wound environment that ensures a continuous fresh supply of therapeutic solutions to the wound. DermaStream is designed to deliver effective, affordable and easy-to-use wound treatment throughout all phases of chronic wound lifecycle, including selective wound debridement (removal of necrotic tissue), bacterial load reduction and enhanced healing. DermaStream was designed for use in hospitals, clinics and home care. EnzySurge is committed to the development and delivery of innovative solutions that improve the quality of life of chronic-wound patients, by shortening healing time and reducing treatment costs. For more information, visit www.dermastream.com.
Nicole Colomb
Phone: (804) 212-2974
Fax: (804) 828-8566
Email: ncolomb@vbcc-inc.com - Fanevil Medical Ltd.
Paul Rocheleau
(804) 780-0031
procheleau@vlsillc.com - Gardia Medical
Gardia Medical specializes in the development of catheter-based delivery systems that easily integrate with the standard workflow of stenting and other cardiovascular intervention procedures. Their proprietary Deliver, Lock and Deploy (DLD) technology consists of an advanced mechanical locking mechanism and stand-alone filter that are delivered via a delivery catheter, and can be positioned in any location along the vessel without compromising guidewire performance. Its modular approach provides a unique and elegant solution in cardiovascular intervention. Gardia is currently introducing the first wire-independent distal filtration Embolic Protection Device (EPD). Compatibility with standard guide wires and the seamless integration with interventional procedure workflow promises to set a new standard for the cardiovascular intervention field.
For More Information: www.gardiamedical.comNicole Colomb
(804) 212-2974
ncolomb@vbcc-inc.com - Global Nutritech
http://www.globalnutritech.com/
Contact: Sandy Akay
sandyakay@gmail.com
- GPB Scientific, LLC
GPB is in the business of selling its proprietary cell separation microchips to life science companies focused on the adult stem cell market. GPB's unique “tools” allow customers to achieve major breakthroughs in separating many more viable stem cells from extracted blood and marrow samples, much quicker and at substantially lower costs than current methods allow.
http://www.gpbscientific.com/
Michael Grisham, managing member
Phone: (804) 225-8809
Fax: (804) 225-8807
Email: mgrisham@gpbscientific.com - IBA Molecular
More Info Coming Soon!
- ImmunArray, Ltd.
ImmunArray is developing a groundbreaking in-vitro diagnostic platform system, the I-Chip, which profiles the antibody repertoire in serum, saliva or urine. The first tests will focus on early diagnosis of lung cancer. These profiles will be used for earlier diagnosis of auto-immune diseases, cancer and other immune-related disorders, as well as for selecting the most suitable treatment and for monitoring the response of the individual patient. The company holds exclusive, worldwide license from the Weizmann Institute of Science to develop and to commercialize the Immuno-Chip technology developed by professors Irun Cohen, who is ImmunArray's Chief Science Officer, and Eytan Domany, who serves as a member of ImmunArray's Scientific Advisory Board.
Donna Edmonds
Phone: (804) 212-2975
Fax: (804) 828-8566
Email: dedmonds@vbcc-inc.com - Kinakeet Biotechnology
Offers quality protein expression and purification services.
http://www.kinnakeet.com/
Ronald P. Magnusson, Ph.D., President
Email: rmagnus@kinnakeet.com
Michele G. Magnusson, MT (ASCP), COO
Phone: (804) 644-3363
Fax: (804) 506-4414 - MedGen LLC
More info to come
- NeatStitch, Ltd.
NeatStitch LTD, an Israeli based company, has developed a novel medical device, NeatClose, that performs automatic suturing of ports in laparoscopic procedures. This technology is based on a unique Nitinol based platform. The company has a distingusished list of Scientific Advisors ecognized for their leadership in the surgical community.
NeatClose is FDA approved, employs a simple-intuitive blunt end design therefore avoiding exposed needles and improving the safety and speed of the closure for each procedure. The NeatClose system includes a reusable handle which is easily sterilized and a disposable pre packaged cartridge.
For More information please visit: http://www.neatstitch.com/
Nicole Colomb
(804) 212-2974
ncolomb@vbcc-inc.com - New Life Innovations
Designs, develops and markets medical products.
Stanley D. Yeatts, II, M.D., founder
Phone: (757) 867-7281 (Yorktown Office)
Email: syky@verizon.net - NuSil Technology, LLC
Produces a variety of silicone materials for use in biomedical, healthcare and engineering applications.
Jim Lambert, Ph.D., Senior Scientist
Phone: (804) 344-0057
Fax: (804) 344-0057
Email: jiml@nusil.com - Obetech, LLC
Provides research resources and laboratory tests to the scientific community, industry, federal agencies, and the general public for viruses that produce obesity. Services include diagnostic assays in humans and animals for obesity viruses by serum neutralization and polymerase chain reaction (PCR), evaluation of effectiveness of antiviral agents, evaluation of immune enhancement properties of antiviral agents and a variety of molecular biology services including molecular cloning, gene expression analysis, and protein expression and purification.
http://www.obesityvirus.com/
Richard L. Atkinson, President
Phone: (804) 344-5360
Fax: (804)827-8230
Email: ratkinson2@vcu.edu - Orthospace
A spin off of BioProtect Ltd., OrthoSpace has developed a biodegradable balloon that can be implant in the shoulder of patients with massive tears in the muscle and tendon. The implant acts as an artificial bursa, minimizing friction between the bones and the surrounding soft tissue and stops the acute reaction associated with the massive tears.
For more information: http://www.orthospace.co.il/
Kate Webster
(804) 212-2299
kwebster@vbcc-inc.com - Respiratory Drug Delivery and RDD Online, LLC
The organization manages the premier, annual international meeting on pulmonary and nasal drug delivery, and through the provision of peer review articles, books, and on-line education offerings, serves as a central resource for companies and organizations concerned with inhaled product biopharmaceutics, novel aerosol formulations, devices, test methods and related regulatory science. RDD Online also provides up-to-date information, education and recruiting services to corporate customers working on inhaled products.
Peter Byron, Ph.D., president
Phone: (804) 827-1490
Fax: (804) 828-8277
Email: info@rddonline.com
Joanne Peart, Ph.D., Associate Professor Department of Pharmaceutics School of Pharmacy, Virginia Commonwealth University 410 North 12th Street Richmond, VA 23298-0533
Phone: (804) 828 6378
Fax: (804) 828 8359 - U.S. Commercial Service
Help export-ready, already established small-to-medium sized companies (SMEs) in Virginia export their goods and services to international markets.
W. Eric McDonald, Director
Phone: (804) 771-2246
Fax: (804) 771-2390 - VCU Academic Molecular Transplant No description.
- VCUHS Transplant
The Hume Lee Cell Transplant Facility is part of the VCU Medical Center Transplant Department and located in the Virginia BioTechnology Research Park. It oversees a cGMP facility that organizes cell transplants for the VCU Medical Center Transplant Surgical Team, in addition to ongoing research that leads to increasing health care options for liver disease and diabetic patients in our community.
Dr. Robert A. Fisher, MD,
Professor and Director of Adult and Pediatric Liver Transplant Programs and Cell Transplant ProgramDr. Adrian Cotterell, MD,
Assoc. Professor, Scientific Director of Islet Txp ProgramDr. Marc Posner, MD Professor and Chairman, Division of Transplant Surgery, Director Transplant Programs Donna George, Nursing Director & Administrator of Transplant Program
Melissa Thompson Sheehan, Operations Manager of Cell Facility Hume Lee Cell Transplant Facility,
VCU Medical Center
800 E. Leigh Street, Suite 59
Virginia BioTechnology Research Park, 2nd floor
Richmond, VA 23219
Phone: (804) 828-2602 - Virginia Biosciences Commercialization Center
Donna Edmonds
Phone: (804) 212-2973
Fax: (804) 828-8566
Email: dedmonds@vbcc-inc.com - Virginia Biosciences Development Center
David R. Lohr, executive director
Phone: (804) 828-7048
Fax: (804) 827-8230
E-mail: drl@vabiotech.comDeneen Terrell, administrative assistant
Phone: (804) 827-VBDC
Fax: (804) 827-8230
E-mail: vbrp@vabiotech.com - Virginia Biotechnology Association
Represents Virginia's bioscience and device industry with more than 150 members throughout the state.
http://www.vabio.org/
Mark A. Herzog, executive director
Phone: (804) 643-6360
Fax: (804) 643-6361
Email: questions@vabio.org - Virginia Life Science Investments
Paul Rocheleau
Chairman of the Board & Chief Investment Officer
(804) 780-0031
procheleau@vlsillc.comTim Black
Chief Financial Officer
(804) 212-2973
tblack@vbcc-inc.com - Virginia Tobacco & Health Research Repository, Inc.
The Virginia Tobacco & Health Research Repository, Inc. (VTHRR) was formed to provide access to data and bio-specimens that researchers, institutions, regulators and companies may require in order to investigate the relationships between smoking and tobacco use and human health indications. The core resource of the VTHRR is the Total Exposure Study, one of the largest studies on smoking patterns and tobacco use ever conducted in the United States, consisting of over 5,000 adult males and females, 21 years of age and older who were in generally good health and were enrolled from 39 investigative sites across the U.S. into various parallel investigative groups. Bio-specimens which were collected from study participants consist of urines, plasmas, RBC’s and PBMC’s.
The VTHRR will be filing for non-profit status with the Internal Revenue Service as a 501-c-3 organization and is governed by a 6 member independent Board of Directors representing major public academic research institutions in Virginia, public health laboratories and major non-profit medical centers.
Contact:
Robert T. Skunda, Chairman
Virginia Tobacco & Health Research Repository, Inc.
800 East Leigh Street
Richmond, VA 23219
(804) 828-5390
rts@vabiotech.com - Virtual Ports, Ltd.
Virtual Ports is developing a suite of products in the field of endoscopic surgery. The company provides the mechanism to improve visibility and maneuverability by establishing a series of tools and that can be placed into the working area - the laparoscopic internal field. The mechanism appears to be ideal for natural-orifice translumenal endoscopic surgery, also known as NOTES, an innovative method of abdominal surgery that does not involve an incision in the abdominal wall, as well as other laparoscopic approaches.
Donna Edmonds
Phone: (804) 212-2975
Fax: (804) 828-8566
Email: dedmonds@vbcc-inc.com - Xenolith Medical
Xenolith Medical is developing the new generation of “stone filters” that allow effective blockage of stone debris migration during ureteroscopic procedures, complete removal of trapped debris and considerable simplification of the overall procedure. The company’s approach combines a ureteroscopic guidewire with a “stone filter” which also serves as a retrieval device (or “basket”) into a all-in-one device.
Kate Webster
(804) 212-2299
kwebster@vbcc-inc.com - XVionics
XVionics' core software technology provides multidimensional dependency scheduling, asset management/total asset visibility, intelligent-decision support and risk management in a collaborative environment with the ability to integrate disparate systems. XVionics has a system that has been proven to be successful in the Israeli medical market and is looking to expand into the North American market. The core technology is based on operating software developed for the defense industry in Israel and is in final stage evaluation for inclusion in the U.S. defense industry.
Donna Edmonds
Phone: (804) 827-8231
Fax: (804) 828-8566
Email: dje@vabiotech.com - Zynnovation LLC
Zynnovation LLC is a Virginia-based green technology and biotechnology company established in March 2010. We believe that novel technologies should contribute more to our everyday life and create more opportunities for economic growth. Zynnovation LLC is developing products based on novel green technologies and biomedical technologies. Currently, we focus on research and development of green roof, bio- and chemical sensor, novel green processing technology, medical devices targeting diabetic patients, and pollution prevention and control.
Hailing Yang Ph.D.
President & CEO
Phone: (540) 239-2902
Fax: (804) 302-9100
Email: hailingyang@gmail.com
